Mosley, Jonathan D. http://orcid.org/0000-0001-6421-2887
Shelley, John P.
Dickson, Alyson L. http://orcid.org/0000-0003-3404-3802
Zanussi, Jacy
Daniel, Laura L. http://orcid.org/0000-0003-3143-5915
Zheng, Neil S.
Bastarache, Lisa
Wei, Wei-Qi http://orcid.org/0000-0003-4985-056X
Shi, Mingjian http://orcid.org/0000-0003-1569-9822
Jarvik, Gail P.
Rosenthal, Elisabeth A. http://orcid.org/0000-0001-6042-4487
Khan, Atlas http://orcid.org/0000-0002-6651-2725
Sherafati, Alborz
Kullo, Iftikhar J. http://orcid.org/0000-0002-6524-3471
Walunas, Theresa L. http://orcid.org/0000-0002-7653-3650
Glessner, Joseph http://orcid.org/0000-0001-5131-2811
Hakonarson, Hakon http://orcid.org/0000-0003-2814-7461
Cox, Nancy J.
Roden, Dan M. http://orcid.org/0000-0002-6302-0389
Frangakis, Stephan G.
Vanderwerff, Brett
Stein, C. Michael
Van Driest, Sara L.
Borinstein, Scott C. http://orcid.org/0000-0002-1721-1520
Shu, Xiao-Ou
Zawistowski, Matthew http://orcid.org/0000-0002-3005-083X
Chung, Cecilia P.
Kawai, Vivian K.
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (R01GM130791, R01GM126535, R35GM131770)
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences
U.S. Department of Health & Human Services | NIH | National Human Genome Research Institute (U01HG006378)
the Ingram Cancer Research Professorship fund, VUMC, Nashville, TN
Article History
Received: 20 August 2023
Accepted: 10 April 2024
First Online: 22 April 2024
Competing interests
: S.C.B. has served on the scientific advisory board for Ipsen Pharmaceuticals and Fennec Pharmaceuticals. The remaining authors declare no competing interests.